Related Experiment Video
Updated: Feb 13, 2026

04:54
Flavonoid Content During the Growth and Floral Development of Calendula officinalis L.
Published on: June 27, 2025
1.1K
New flavonoids from Portulaca oleracea L. and their activities
Xu Yang1, Wenjie Zhang1, Xixiang Ying1
1School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, PR China.
Fitoterapia
|March 5, 2018
Summary
Three new compounds and three known compounds were isolated from Portulaca oleracea. Oleracone C, D, and E showed significant antioxidant and anticholinesterase activities, indicating potential therapeutic applications.
Area of Science:
- Phytochemistry
- Natural Products Chemistry
- Pharmacology
Background:
- Portulaca oleracea L. (purslane) is a widely distributed plant with a history of traditional medicinal use.
- Investigating the chemical constituents of P. oleracea can lead to the discovery of novel bioactive compounds.
Purpose of the Study:
- To isolate and characterize new and known compounds from Portulaca oleracea.
- To evaluate the antioxidant and anticholinesterase activities of the isolated compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation through comprehensive spectroscopic methods including 1D/2D NMR, HR-ESI-TOF-MS, and CD spectrometry.
- In vitro assays for DPPH radical scavenging and anticholinesterase activity.
Main Results:
- Six compounds were isolated: three new (oleracone C, D, E, and cycloflavan 3) and three known flavanone and chalcone derivatives.
- Oleracone C, D, and E exhibited DPPH radical scavenging activity with IC50 values ranging from 11.73 to 23.27 μM.
- These compounds also demonstrated anticholinesterase activity with IC50 values between 59.55 and 78.85 μM.
Conclusions:
- The study successfully identified novel compounds from Portulaca oleracea.
- Oleracone C, D, and E possess significant antioxidant and anticholinesterase properties, suggesting their potential as therapeutic agents.
Related Concept Videos
Co-activators and Co-repressors
8.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
tRNA Activation
23.1K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.1K
Activation Energy
87.2K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
87.2K
Eukaryotic Transcription Activators
12.9K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.9K
Secondary Active Transport
138.3K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
138.3K
Primary Active Transport
201.0K
In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
201.0K

